Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.75B |
| 2 |
Walmart Inc
WMT
|
+$3.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.42B |
| 4 |
Broadcom
AVGO
|
+$943M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$785M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$572M |
| 2 |
NVIDIA
NVDA
|
+$566M |
| 3 |
Apple
AAPL
|
+$554M |
| 4 |
AbbVie
ABBV
|
+$455M |
| 5 |
Bank of America
BAC
|
+$411M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.24% |
| 2 | Technology | 9.52% |
| 3 | Healthcare | 7.46% |
| 4 | Financials | 6.74% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Enterprise Financial Services Corp
EFSC
$2.3B
| $5.67M | ﹤0.01% |
105,077
+100,281
| +2,091% | +$5.51M |
|
2777
ArriVent BioPharma
AVBP
$1.49B
| $5.67M | ﹤0.01% |
281,952
-4,152
| -1% | -$86.4K |
|
2778
PUT
EOG Resources
EOG
$75.2B
| $5.67M | ﹤0.01% |
54,000
-52,000
| -49% | -$5.59M |
|
|
BETA
2779
Beta Technologies Inc
BETA
$4.72B
| $5.66M | ﹤0.01% |
+200,657
| New | +$5.99M |
|
|
ALX
2780
Alexander's
ALX
$1.38B
| $5.66M | ﹤0.01% |
25,950
+2,015
| +8% | +$450K |
|
2781
CALL
General Mills
GIS
$22.2B
| $5.64M | ﹤0.01% |
121,300
+6,000
| +5% | +$285K |
|
2782
International Money Express
IMXI
$437M
| $5.63M | ﹤0.01% |
366,243
+48,572
| +15% | +$729K |
|
2783
PUT
PACCAR
PCAR
$66B
| $5.62M | ﹤0.01% |
51,300
+4,500
| +10% | +$461K |
|
2784
CALL
Coeur Mining
CDE
$21.7B
| $5.62M | ﹤0.01% |
+315,000
| New | +$5.48M |
|
2785
Vodafone
VOD
$37.1B
| $5.61M | ﹤0.01% |
425,053
-2,734,951
| -87% | -$33.1M |
|
2786
Sportradar
SRAD
$3.83B
| $5.6M | ﹤0.01% |
235,716
-7,963
| -3% | -$192K |
|
2787
Usana Health Sciences
USNA
$259M
| $5.6M | ﹤0.01% |
285,416
+250,424
| +716% | +$5.2M |
|
2788
Moody's
MCO
$89.2B
| $5.6M | ﹤0.01% |
10,954
-29,688
| -73% | -$14.5M |
|
2789
DNOW Inc
DNOW
$2.88B
| $5.59M | ﹤0.01% |
421,740
-135,996
| -24% | -$1.91M |
|
2790
CALL
Transmedics
TMDX
$3.07B
| $5.58M | ﹤0.01% |
45,900
-26,700
| -37% | -$3.35M |
|
2791
CALL
Duke Energy
DUK
$93.8B
| $5.58M | ﹤0.01% |
47,600
-58,500
| -55% | -$7.14M |
|
2792
Kyverna Therapeutics
KYTX
$518M
| $5.58M | ﹤0.01% |
593,369
+41,734
| +8% | +$310K |
|
2793
Enact Holdings
ACT
$6.75B
| $5.55M | ﹤0.01% |
140,093
-36,863
| -21% | -$1.39M |
|
2794
Phinia Inc
PHIN
$2.52B
| $5.55M | ﹤0.01% |
88,490
-67,776
| -43% | -$3.75M |
|
2795
Lexicon Pharmaceuticals
LXRX
$1.02B
| $5.54M | ﹤0.01% |
4,821,733
+991,073
| +26% | +$1.36M |
|
|
ARDT
2796
Ardent Health
ARDT
$1.55B
| $5.54M | ﹤0.01% |
627,435
-642,170
| -51% | -$7.42M |
|
|
ANDG
2797
Andersen Group
ANDG
$6.3B
| $5.54M | ﹤0.01% |
+213,648
| New | +$5.37M |
|
2798
PUT
Paychex
PAYX
$45.2B
| $5.52M | ﹤0.01% |
49,200
-124,400
| -72% | -$14.6M |
|
|
LWAC
2799
LightWave Acquisition Corp
LWAC
| $5.52M | ﹤0.01% |
+550,000
| New | +$5.53M |
|
2800
Virtus Investment Partners
VRTS
$1.13B
| $5.51M | ﹤0.01% |
33,768
+3,391
| +11% | +$573K |
|
Similar funds
Israel Englander's Q4 2025 Portfolio in Review
As of Q4 2025, Israel Englander held 6,645 positions worth $238B, up 1.5% from $234B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Israel Englander's Q4 2025 filing shows 668 new, 2,203 increased, 2,701 reduced and 696 closed positions. Its largest new stake was iShares Russell 1000 ETF: 455,129 shares worth $170M. The largest sale was Microsoft, an estimated $572M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2025 buy was iShares Russell 1000 ETF: 455,129 shares worth $170M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $4.75B increase.
- Israel Englander's biggest Q4 2025 reduction was Microsoft, cutting an estimated $572M.
- Israel Englander fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Israel Englander's ten largest holdings make up 19% of its $238B portfolio in Q4 2025.
- Israel Englander opened 668 new positions and closed 696 in Q4 2025.
- Israel Englander's portfolio value rose 1.5% quarter-over-quarter to $238B.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.